N@N

Prakhar Agrawal Reiterated (AKRO) at Buy on, Jun 12th, 2024

Prakhar Agrawal of Cantor Fitzgerald, Reiterated "Akero Therapeutics, Inc." (AKRO) at Buy on, Jun 12th, 2024.

Prakhar has made no other calls on AKRO in the last 4 months.

There are 6 other peers that have a rating on AKRO. Out of the 6 peers that are also analyzing AKRO, 1 agrees with Prakhar's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Alexandria Hammond of "B of A Securities" Initiated at Hold and Held Target at $30 on, Monday, April 22nd, 2024

These are the ratings of the 5 analyists that currently disagree with Prakhar

---

• Andy Chen of "Wolfe Research" Initiated at Buy on, Tuesday, June 11th, 2024
• Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Tuesday, June 11th, 2024
• Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $38 on, Wednesday, May 15th, 2024
• Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $56 on, Monday, May 13th, 2024
• Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, March 5th, 2024

Contributing Sources

---